hematopoietic progenitor kinase 1 inhibitors (RAPT Therapeutics)

N/A

Report date: 2025/01/26 18:00:06
NME

Base Information

Drug Namehematopoietic progenitor kinase 1 inhibitors (RAPT Therapeutics)
Drug Alias NameHPK1 inhibitors (RAPT Therapeutics)HPK1-054
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase kinase kinase kinase 1 inhibitors
TargetsMitogen-activated protein kinase kinase kinase kinase 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRapt Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRapt Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A